Transactions

TiVo and Xperi edge towards merger, and the creation of a $500 million licensing giant

The key questions that need to be answered as plans take shape to spin-off the combined IP businesses into a standalone company

TiVo and Xperi edge towards merger, and the creation of a $500 million licensing giant
20 Feb 2020

After IBM selloff more former Big Blue assets end up in litigation

NPE targets Uber in new infringement suit in West Texas; follows case against Chinese drone leader earlier this month

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today

Latest

View all
18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions Read more

17 Feb 2020

Irish NPE doubles down on US litigation campaign and continues to add patents

Recent transfer of more than 50 assets from Microchip Technology suggests there might be more litigation on the way from Neodrón   Read more

15 Feb 2020

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year Read more

14 Feb 2020

Five keys to successful technology licensing with the not-for-profit community

Huge amounts of innovation in the university and wider research worlds remain untapped but there are some clear tips to follow as companies search for new sources of value Read more

News

View all
6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

1 Feb 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate Read more

30 Jan 2020

Global IP Awards winners for 2020 named in London

Law and attorney firms from around the world recognised for their outstanding work in litigation, prosecution and transactions during 2019 Read more

28 Jan 2020

Shanghai research group to license SEPs through Sisvel

Langbo Communications Technology CEO Yang Lin tells IAM he’s hoping to build “China’s InterDigital” Read more

Analysis

View all
13 Feb 2020

Slack the latest tech company to pick up former Yahoo! assets

As parent company winds itself up, Excalibur IP keeps doing deals - although big syndicated transaction remains elusive Read more

12 Feb 2020

Patent transfer sets stage for possible Ant Financial IPO

Assets assigned to the Alipay operator financed Alibaba’s purchase of a 33% stake in what could be one of the biggest Asian listings ever Read more

11 Feb 2020

Antitrust considerations now a much bigger factor in pharma patent dealmaking

Following recent forced divestments - and with growing political concern about life sciences acquisitions - the signs are that regulators will play a larger role in transactions Read more

11 Feb 2020

Toshiba patent disposals continue with Toyota deal

Transaction comes shortly after former Toshiba patents appeared in US NPE litigation against Fiat Chrysler Read more

Insights

View all
30 Aug 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Find an expert

Daniel M McGavock
Vice President
Chicago IL, United States
Charles River Associates